Ulcerative colitis: An immunological disease?

Bailliere's Clinical Gastroenterology

Volumn 11, Issue 1, 1997, Pages 35-52

  Radford Smith, Graham ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

ANCA; Auto immunity; B cell; Cytokines; Oligoclonality; T cell; Tolerance

Indexed keywords

ANTIGEN; CORTICOSTEROID; CYTOKINE;

ANTIGEN PRESENTATION; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; COLON MUCOSA; CYTOTOXICITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

EID: 0030986831     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(97)90052-X     Document Type: Article

References (88)

1. Babyatsky M, Rossiter G et al (1996) Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110: 975-984.
2. Balkwill FR & Burke F (1989) The cytokine network [see comments]. Immunology Today 10: 299-304.
3. Bhagat, S & Das K (1994) A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. Gastroenterology 107: 103-108.
4. Blaser M, Miller R et al (1984) Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 87: 888-894.
5. Blumberg R, Yockey C et al (1993) Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple Vβ T cell receptor genes. Journal of Immunology 150: 5144-5153.
6. Bookman M & Bull D (1979) Characteristics of isolated intestinal mucosa lymphoid cells in inflammatory bowel disease. Gastroenterology 77: 513-520.
7. Broberger & Perlmann P (1959) Autoantibodies in human ulcerative colitis. Journal of Experimental Medicine 110: 657-674.
8. Carlsson H, Hammarstroms S et al (1971) Antibody-induced destruction of colon antigen-coated chicken erythrocytes by normal human lymphocytes. European Journal of Immunology 1: 281-285.
9. Carlsson H, Lagercrantz R et al (1977) Immunological studies in ulcerative colitis VIII: antibodies to colon antigen in patients with ulcerative colitis, Crohn's disease and other diseases. Scandinavian Journal of Gastroenterology 12: 707-714.
10. Casini-Raggi V, Kam L et al (1995) Mucosal imbalance of interleukin-1 and interleukin-1 receptor antagonist(IL-1ra) in inflammatory bowel disease: a novel mechanism of chronic inflammation. Journal of Immunology 154: 2434-2440.
11. +-intestinal mucosa T cells in ulcerative colitis. Journal of Immunology 156: 3024-3035.
12. Cominelli F, Nast CC et al (1990) Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. Journal of Clinical Investigation 86: 972-980.
13. Dalton DK, Pitts MS et al (1993a) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
14. Dalton HR, Dipaolo MC et al (1993b) Human colonic intraepithelial lymphocytes from patients with inflammatory bowel disease fail to down-regulate proliferative responses of primed allogeneic peripheral blood mononuclear cells after rechallenge with antigens. Clinical and Experimental Immunology 93: 97-102.
15. Das K, Dubin R et al (1978) Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis. Proceedings of the National Academy of Sciences of the USA 75: 4528-4532.
16. Das KM, Vecchi M et al (1990) A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology 98: 464-469.
17. Das KM, Dasgupta A et al (1993) Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis. Journal of Immunology 150: 2487-2493.
18. Dignass AU & Podolsky DR (1993) Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 105: 1323-1332.
19. Duchmann R, Kaiser I et al (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clinical and Experimental Immunology 102: 448-455.
20. Duchmann R, Marker-Hermann E et al (1996) Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scandinavian Journal of Immunology 44: 71-79.
21. Duerr R & Neigut D (1995) Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 108: 423-427.
22. Eisenberg SP, Evans RJ et al (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343: 341-346.
23. Fiocchi C, Hilfiker ML et al (1984) interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 86: 734-742.
24. Fuss I, Neurath M et al (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Journal of Immunology 157: 1261-1270.
25. Gibson PR, van de Pol E et al (1988) Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease. Gut 29: 1076-1084.
26. + population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clinical and Experimental Immunology 100: 291-297.
27. Halstensen TS, Das KM et al (1993) Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut 34: 650-657.
28. Hart P, Ahern M et al (1993) Synovial fluid macrophages and blood monocytes differ in their response to IL-4. Journal of Immunology 151: 3370-3380.
29. Heddle R & Shearman D (1979) Serum antibodies to Escherichia coli in subjects with ulcerative colitis. Clinical and Experimental Immunology 38: 22-30.
30. Heiner DC (1984) Significance of immunoglobulin G subclasses. American Journal of Medicine 76: 1-6.
31. Hoang P, Dalton HR et al (1991) Human colonic intra-epithelial lymphocytes are suppressor cells. Clinical and Experimental Immunology 85: 498-503.
32. Hogan PG, Hapel AJ et al (1985) lymphokine-activated and natural killer cell activity in human intestinal mucosa. Journal of Immunology 135: 1731-1738.
33. Hoyne GF, Callow MG et al (1993) Comparison of antigen presentation by lymph node cells from protein and peptide-primed mice. Immunology 78: 58-64.
34. Kaulfersch W, Fiocchi C et al (1988) Polyclonal nature of the intestinal mucosal lymphocyte populations in inflammatory bowel disease. A molecular genetic evaluation of the immunoglobulin and T-cell antigen receptors. Gastroenterology 95: 364-370.
35. Khoury SJ, Hancock WW et al (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down regulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. Journal of Experimental Medicine 176: 1355-1364.
36. Ma A, Datta M et al (1995) The development of colitis in interleukin-2 knockout mice still occurs when these mice are bred with B cell-deficient mice. Journal of Experimental Medicine 182: 1567-1572.
37. MacDermott R, Franklin G et al (1980) Human intestinal mononuclear cells I. Investigation of antibody-dependent, lectin-induced and spontaneous cell-mediated cytotoxic capabilities. Gastroenterology 78: 47-56.
38. MacDermott R, Beale M et al (1983) Synthesis and secretion of IgA, IgM, and IgG by peripheral blood mononuclear cells in human disease states, by isolated human intestinal mononuclear cells, and by human bone marrow mononuclear cells from ribs. In McGhee JR & Mestecky J (eds) The Secretory Immune System. New York: New York Academy of Sciences 498.
39. MacDermott RP, Nash GS et al (1986) Altered patterns of secretion of monomeric IgA and IgA subclass I by intestinal mononuclear cells in inflammatory bowel disease. Gastroenterology 91: 379-385.
40. MacDermott RP, Nash GS et al (1987) Altered patterns of secretion of IgA and IgG subclasses by ulcerative colitis and Crohn's disease intestinal mononuclear cells. Advances in Experimental Medicine and Biology 216A: 335-344.
41. MacDermott RP, Schloemann SR et al (1989) inhibition of antibody secretion by 5-aminosalicylic acid. Gastroenterology 96: 442-448.
42. Macpherson A, Khoo U et al (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38: 365-375.
43. Maggi E, Parronchi P et al (1992) Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. Journal of Immunology 148: 2142-2147.
44. Mayer, L & Eisenhardt D (1990) Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. Journal of Clinical Investigation 86: 1255-1260.
45. Mayer L, Eisenhardt D et al (1991) Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease [see comments]. Gastroenterology 100: 3-12.
46. Melamed D & Friedman A (1993) Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. European Journal of Immunology 23: 935-942.
47. Miller A, Lider O et al (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGF-β following antigen specific triggering. Proceedings of the National Academy of Sciences of the USA 89: 421-425.
48. Mombaerts P, Mizoguchi E et al (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice [see comments]. Cell 75: 274-282.
49. Mosmann TR & Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 7: 145-173.
50. Mullin GE, Lazenby AJ et al (1992) Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 102: 1620-1627.
51. Mullin G, Vezza F et al (1993) Abnormal IL10 mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 104: A751.
52. Neurath M, Fuss I et al (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. Journal of Experimental Medicine 182: 1281-1290.
53. Nickoloff B & Turka L (1994) Immunological functions of non-professional antigen-presenting cells: new insights from studies of T cell interactions with keratinocytes. Immunology Today 15: 464-469.
54. Niessner M & Volk B (1995a). Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcription-polymerase chain reaction (RT-PCR). Clinical and Experimental Immunology 101: 428-435.
55. Niessner M & Volk B (1995b). Phenotypic and immunoregulatory analysis of intestinal T-cells in patients with inflammatory bowel disease: evaluation of an in vitro model. European Journal of Clinical Investigation 25: 155-164.
56. Okazaki K, Morita M et al (1993) Major histocompatibility antigen-restricted cytotoxicity in inflammatory bowel disease. Gastroenterology 104: 384-391.
57. Owen R, Pierce N et al (1986) M cell transport of Vibrio cholerae from the intestinal lumen to Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. Journal of Infectious Diseases 153: 1108-1118.
58. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. Journal of Experimental Medicine 179: 589-600.
59. Qiao L, Schurmann G et al (1993) Human intestinal mucosa alters T-cell reactivities. Gastroenterology 105: 814-819.
60. Radford-Smith G & Jewell DP (1996) Cytokines and inflammatory bowel disease. In Goodlad RA & Wright NA (eds) Cytokines and Growth Factors in Gastroenterology, Baillière's Clinical Gastroenterology 10(1): 135-164. London: WB Saunders.
61. Raedler A, Fraenkels et al (1985) elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors. Clinical and Experimental Immunology 60: 518-524.
62. Reumaux D, Meziere C et al (1995) distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease. Clinical Immunology and Immunopathology 77: 349-357.
63. Roche JK, Fiocchi C et al (1985) sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro. Journal of Clinical Investigation 75: 522-530.
64. Rudolph U, Finegold M et al (1995) G(i2)alpha protein deficiency: a model for inflammatory bowel disease. Journal of Clinical Investigation 15 (supplement): S101-S105.
65. Rutgeerts P, Goboes K et al (1991) Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338: 771-774.
66. Rutgeerts P, Hiele M et al (1995) Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108: 1617-1621.
67. Sadlack B, Merz H et al (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261.
68. Sartor RB (1994) Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106: 533-539.
69. Schreiber S, MacDermott RR et al (1991) Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 101: 1020-1030.
70. Schreiber S, Heinig T et al (1995a) Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108: 21-33.
71. Schreiber S, Heinig T et al (1995b) Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108: 1434-1444.
72. Scott B, Goodall A et al (1983), Rectal mucosa plama cells in inflammatory bowel disease. Gut 24: 519-524.
73. Shanahan F, Deem R et al (1988), Human mucosal T-cell cytotoxicity. Gastroenterology 94: 960-967.
74. Shanahan F, Leman B et al (1989) Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease. Journal of Clinical Immunology 9: 55-64.
75. Shanahan F, Duerr R et al (1992) Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 103: 456-464.
76. Soderstrom K, Bucht A et al, (1996) Increased frequency of abnormal γδ T cells in blood of patients with inflammatory bowel diseases. Journal of Immunology 156: 2331-2339.
77. van Spreeuvel JP, van Lindeman J et al (1985) A quantitative study of immunoglobulin containing cells in the differential diagnosis of acute colitis. Journal of Clinical Pathology 38: 774-777.
78. Targan S, Landers C et al, (1995a) Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. Journal of Immunology 155: 3262-3267.
79. Targan S, Landers C et al (1995b) High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 108: 1159-1166.
80. Vidrich A, Lee J et al (1995), Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. Journal of Clinical Immunology 15: 293-299.
81. Viney J, Dianda L et al (1994) Lymphocyte proliferation in mice congenitally deficient in T-cell receptor αβ+ T cells. Proceedings of the National Academy of Sciences of the USA 91: 11 948-11954.
82. Weiner H, Friedman A et al (1994) Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annual Review of Immunology 12: 809-837.
83. West G, Matsuura T et al (1996) Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology 110: 1683-1695.
84. Willerford D, Chen J et al (1995) Interleukin-2 receptor α regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521-530.
85. Yacyshyn B (1993) Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis. Immunology and Cell Biology 71: 265-274.
86. Yamamura M, Uyemura K et al (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions [published erratum appears in Science 1992 Jan 3; 255(5040): 12]. Science 254: 277-279.
87. Yang H, Rotter JI et al (1993) Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. Journal of Clinical Investigation 92: 1080-1084.
88. Yang P, Jarnerot G et al (1995) P-ANCA in monozygotic twins with inflammatory bowel disease. Gut 36: 887-890.